Read the record in context
A source-reading guide to sermorelin that distinguishes an older FDA product record from a current compounded offering and helps readers assess what commercial wellness language actually establishes.
Explore the detailsA closer look
A shared ingredient name can make very different records look interchangeable. Source Digest asks what each source identifies: a particular product, an indication, a historical approval or a current commercial listing. Keeping those details together prevents an older sermorelin record from being used to imply approval of a different preparation or purpose.
CoreAge Rx is promoted here. As of November 7, 2026, its general sermorelin page advertised a starting price of $99 per month, with no verified holiday discount. The provider describes a compounded preparation. This digest does not supply a clinical review, establish adult wellness benefits or verify enrollment and dispensing.
The reading room
Keep the product, population and indication attached to an older sermorelin record so it cannot be mistaken for approval of a current compounded wellness preparation.
Read sermorelin marketing by identifying the kind of statement being made and the evidence needed before it can support a claim about patient outcomes.
THE
PROVIDER
RECORD
Sponsored · CoreAge Rx
Prices below are advertised by CoreAge Rx. Confirm eligibility, current terms, and total charges with the provider before enrolling.
Regular product listing
Provider-advertised starting price
No Black Friday or Cyber Monday discount has been verified. Confirm commitment, current charges and renewal terms.
Compounded medication is not FDA-approved. A clinician must assess your needs; a prescription is not guaranteed.
Provider sourcePromotional placement. This publication is part of a commonly owned promotional network supporting CoreAge Rx. Placement is not an independent ranking or a claim that treatment is appropriate for you. How this site works.
Before you decide
FDA records identify an older sermorelin product, Geref, with a pediatric growth-hormone-deficiency indication. That is a specific historical product record. It does not approve CoreAge Rx’s current compounded preparation or establish approval for adult wellness or anti-aging uses.
The provider describes its sermorelin offering as compounded, and compounded preparations are not FDA-approved. A shared ingredient name does not transfer an older product’s approval to a new preparation. Ask the clinician to explain the exact product being considered.
A commercial description can show what the provider promotes, but it does not by itself demonstrate a clinical outcome. Ask for evidence that matches the proposed preparation, intended use and relevant population rather than relying on broad claims about aging or recovery.
No sermorelin holiday discount was verified as of November 7, 2026. CoreAge Rx’s general listing advertises a starting price of $99 per month. The holiday name of this guide should not be read as confirmation of a sale.
Take this with you
Which exact product and indication does the cited FDA record concern?
How does that record differ from the proposed compounded preparation?
What evidence supports any benefit claimed for the intended use?
What current price, plan period and clinical review conditions apply to this listing?